<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03585868</url>
  </required_header>
  <id_info>
    <org_study_id>COFRE-LIICM</org_study_id>
    <nct_id>NCT03585868</nct_id>
  </id_info>
  <brief_title>Effects of COcoa Supplement in FRail Elderly Subjects (COFRE)</brief_title>
  <acronym>COFRE</acronym>
  <official_title>Evaluation of the Effects of a COcoa Supplement to Reduce FRailty in the Elderly: COFRE a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Polytechnic Institute, Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Polytechnic Institute, Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study use a double blind, placebo-controlled design enrolling male and female subjects
      between 55-90 yo to evaluate the effect of daily consumption of a cocoa beverage on
      anthropometric, metabolic, oxidative stress, physical performance and quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study use a double blind, placebo-controlled design enrolling male and female subjects
      between 55-90 yo randomly assigned to consumption of a flavonoid rich mixture (flavonoids;
      F), alkalinized cocoa which eliminates flavonoid content (no flavonoids; NF) or placebo. All
      beverages had similar physical characteristics and flavor. Cocoa beverages were provided in
      individual sachets containing a dry powder that was reconstituted with water just before
      consumption. Subjects were instructed as above to maintain their usual lifestyle, to limit
      intake of high caloric foods and flavonoid-containing foods and beverages, and to walk for 30
      min/day.

      To determine the effect of flavonoids, study evaluates anthropometric measures, metabolic
      parameters as glycemia and a lipid profile (triglycerides, total cholesterol, high-density
      lipoprotein cholesterol and low-density lipoprotein cholesterol). To evaluate oxidative
      stress damage as lipid oxidation is measured with the malondialdehyde (MDA) assay. Protein
      carbonylation is measured using an assay for detection of carbonyl groups that relies on
      2,4-dinitrophenylhydrazine (DNPH) as a substrate. The investigators also evaluate
      interleukin-6 and tumor necrosis factor levels.

      For physical performance is evaluated the handgrip strength, and mobility assesment with the
      following test: Six-minute walk test, two-minute step, sit-up test and the up &amp; go test.

      The investigators also assessed quality of life using the Health Related QoL (EQ-5D)
      questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum triacylglycerol concentration</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum total cholesterol</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum HDL cholesterol</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum LDL cholesterol</measure>
    <time_frame>At 90 days</time_frame>
    <description>Fasting blood level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lipid oxidation</measure>
    <time_frame>At 90 days</time_frame>
    <description>Serum malondialdehyde Levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Protein oxidation</measure>
    <time_frame>At 90days</time_frame>
    <description>Serum protein carbonylation Levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Handgrip strength</measure>
    <time_frame>At 60 days</time_frame>
    <description>Measures static force in kilograms that the hand can squeeze around a dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Up and go test</measure>
    <time_frame>At 60 days</time_frame>
    <description>Measures time in seconds, a subject can rise and walk a 3-meter line and return to sit down</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute walk test</measure>
    <time_frame>6 minutes</time_frame>
    <description>Measures maximum distance in meters, a subject can walk at their normal gait and pace during 6 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Two-minute step in place test</measure>
    <time_frame>2 minutes</time_frame>
    <description>Measures number of times a subject can rise each knee to the hip level during 2 minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sit-up test</measure>
    <time_frame>30 seconds</time_frame>
    <description>Measures number of times a subject can rise and sit-down in place during 30 seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D questionnaire</measure>
    <time_frame>At 60 days</time_frame>
    <description>Self-administered health index that explores five domains</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analog Visual Scale</measure>
    <time_frame>At 60 days</time_frame>
    <description>Use of a Analog Visual Scale to measure the quality of life, graded 0 (worst) to 100 (best) for the perception of wellbeing.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Sarcopenia</condition>
  <condition>Frail Elderly Syndrome</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Beverage without flavonoids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Flavonoids</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Beverage with alkalinized cocoa which eliminates flavonoid content</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flavonoids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Beverage with a flavonoid rich mixture</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Beverage with no flavonoids</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flavonoids</intervention_name>
    <description>Flavonoids-enriched cacao beverage</description>
    <arm_group_label>Flavonoids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>No Flavonoids</intervention_name>
    <description>Beverage with alkalinized cocoa which eliminates flavonoid content</description>
    <arm_group_label>No Flavonoids</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sex: both

          -  Age: 55-90 yo

          -  Waist circumference: Women &gt; 80 cm, Men &gt; 90 cm

          -  HDL-c: Women &lt; 50 mg/dL, Men &lt; 40 mg/dL

          -  Triglycerides: ≥ 150 mg/dL

          -  Glycemia: ≈100 mg/dL

          -  Hand strength: Women&lt; 20 kg, Men &lt; 30 kg

          -  Up &amp; Go test: &gt; 10 seconds

        Non-inclusion criteria:

          -  Any active infections

          -  Malignancies

          -  Habitual consumers of antioxidant supplements and cocoa products

          -  Use of benzodiazepines or protein supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>May 16, 2018</study_first_submitted>
  <study_first_submitted_qc>July 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2018</study_first_posted>
  <last_update_submitted>July 12, 2018</last_update_submitted>
  <last_update_submitted_qc>July 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Polytechnic Institute, Mexico</investigator_affiliation>
    <investigator_full_name>Guillermo Ceballos Reyes</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>flavonoids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

